Moving into the position of National Pharma & Life Sciences Leader, PwC’s Rami El-Cheikh announces the firm’s plan to introduce the comprehensive Pharma Advisory Services currently existing in the US into Canada, including enterprise and function-specific service expertise. He further identifies areas of potential growth in healthcare-related industries, putting forward the tremendous opportunities that lie in the medical cannabis field.
What is the scope of PwC’s pharma and life sciences practice in Canada today?
"We are well-positioned to assist pharma companies in analyzing the medical cannabis landscape, understanding the implications on their core business and exploring market entry options if medical cannabis is of interest to them."
